文献速递性腺与生殖内分泌垂体与肾上腺疾病

FSH刺激后抑制素B(FSH-iB):准确预测延迟青春期青春期结局的新标志物

FSH-stimulated Inhibin B (FSH-iB): A Novel Marker for the Accurate Prediction of Pubertal Outcome in Delayed Puberty.
PubMed 文献 · J Clin Endocrinol Metab · 2021-01-01

研究纳入探索队列42例(含健康儿童26例和低促性腺激素性性腺功能减退症患者16例)及验证队列19例,比较FSH刺激试验与GnRH类似物刺激试验中基础及FSH刺激后抑制素B对青春期启动的预测价值。探索队列显示健康儿童FSH-iB显著升高而HH患者无显著变化,男性cutoff 116.14 pg/mL、女性116.50 pg/mL时灵敏度和特异度均达100%,验证队列中FSH-iB的阳性预测值、阴性预测值和诊断准确率均为100%。

要点

  • 健康儿童外源性FSH刺激后抑制素B显著升高,HH患者无显著升高。
  • FSH-iB男性cutoff 116.14 pg/mL、女性116.50 pg/mL预测青春期启动灵敏度和特异度均100%。
  • 验证队列中FSH-iB预测青春期启动的阳性预测值、阴性预测值和诊断准确率均100%。

核心结论

  • 抑制素B在男性和女性中均可被FSH刺激,FSH-iB可作为预测青春期启动的新颖且有前景的检查。

研究设计与样本

  • 探索队列42例,其中健康儿童(SP)26例、低促性腺激素性性腺功能减退症(HH)患者16例;验证队列19例为因延迟青春期就诊的儿童。
  • 参与者接受FSH刺激试验和GnRH类似物刺激试验,探索队列得出的基础及FSH刺激后抑制素B cutoff应用于验证队列。
  • 前瞻性随访比较基础LH、GnRH类似物刺激后LH、基础抑制素B和FSH-iB与临床结局对青春期启动的预测。

主要发现

  • 探索队列中健康儿童(SP)外源性FSH后抑制素B显著升高,男性升高188.8 pg/mL(P=0.002),女性升高1065 pg/mL(P=0.023)。
  • HH患者(group 2)男女两性抑制素B升高均无统计学显著性。
  • FSH-iB男性cutoff 116.14 pg/mL、女性cutoff 116.50 pg/mL时,预测进入青春期的灵敏度和特异度均为100%。
  • 验证队列中应用上述cutoff,FSH-iB预测青春期启动的阳性预测值、阴性预测值和诊断准确率均为100%。

关键数值与推荐

  • FSH-iB预测青春期启动的cutoff:男性116.14 pg/mL,女性116.50 pg/mL。
  • 该cutoff在探索队列中灵敏度和特异度均为100%,在验证队列中阳性预测值、阴性预测值和诊断准确率均为100%。

临床怎么用

  • 对延迟青春期儿童,可考虑行FSH刺激试验检测FSH-iB,以男性116.14 pg/mL、女性116.50 pg/mL为参考cutoff预测青春期启动。

局限性

  • 结论需未来研究进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Clinicians have long been struggling to find an effective tool to predict onset of puberty. OBJECTIVE: To explore stimulability of inhibin B after exogenous FSH and its potential role for prediction of onset of puberty. DESIGN AND PARTICIPANTS: Study subjects were enrolled into "exploratory cohort" (n = 42) and "validation cohort" (n = 19). The exploratory cohort was further divided into group 1 (healthy children with spontaneous puberty [SP], n = 26) and group 2 (patients with hypogonadotropic hypogonadism [HH], n = 16). The validation cohort included children who presented with complaints of delayed puberty. INTERVENTION AND OUTCOME: Participants were subjected to FSH stimulation test and GnRH analogue stimulation test. Cutoffs derived from the exploratory cohort for basal and FSH stimulated inhibin B (FSH-iB) were applied on the validation cohort. Basal LH, GnRH analogue-stimulated LH, basal inhibin B, and FSH-iB were compared with clinical outcomes on a prospective follow-up for prediction of onset of puberty. RESULTS: There was statistically significant increment in inhibin B after exogenous FSH in group 1 (SP) in both male (188.8 pg/mL; P = 0.002) and female (1065 pg/mL; P = 0.023) subjects. The increment was not statistically significant in group 2 (HH) in both sexes. FSH-iB at a cutoff of 116.14 pg/mL in males and 116.50 pg/mL in females had 100% sensitivity and specificity for labelling entry into puberty. On application of these cutoffs on the validation cohort, FSH-iB had 100% positive predictive value, negative predictive value, and diagnostic accuracy for prediction of pubertal onset. CONCLUSION: Inhibin B was stimulable in both male and female subjects. FSH-iB can be considered a novel and promising investigation for prediction of onset of puberty. Future studies are required for further validation.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Chaudhary S, Walia R, Bhansali A, et al. FSH-stimulated Inhibin B (FSH-iB): A Novel Marker for the Accurate Prediction of Pubertal Outcome in Delayed Puberty. J Clin Endocrinol Metab. 2021. PMID: 34010394. doi:10.1210/clinem/dgab357

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。